Jagsonpal Pharmaceuticals Limited (NSE:JAGSNPHARM)
India · Delayed Price · Currency is INR 230.50
-5.54 (-2.35%)
Jul 31, 2026, 3:30 PM IST
Jagsonpal Pharmaceuticals Market Cap
Jagsonpal Pharmaceuticals has a market cap or net worth of 15.22 billion as of July 31, 2026. Its market cap has decreased by -19.10% in one year.
Market Cap
15.22B
Enterprise Value
14.24B
Revenue
2.94B
Ranking
n/a
PE Ratio
34.43
Stock Price
230.50
ChartMarket Cap Chart
Since March 1, 2000, Jagsonpal Pharmaceuticals's market cap has decreased from 17.63B to 15.22B, a decrease of -13.70%. That is a compound annual growth rate of -0.56%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 15.22B | 18.30% |
| Dec 31, 2025 | 12.86B | -20.68% |
| Dec 31, 2024 | 16.22B | 58.61% |
| Dec 29, 2023 | 10.22B | 4.69% |
| Dec 30, 2022 | 9.77B | 108.36% |
| Dec 31, 2021 | 4.69B | 150.03% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Innova Captab | 55.48B |
| Orchid Pharma | 50.73B |
| RPG Life Sciences | 45.95B |
| Solara Active Pharma Sciences | 24.47B |
| Beta Drugs | 22.24B |
| Indoco Remedies | 20.00B |
| Sakar Healthcare | 19.70B |
| Ind-Swift Laboratories | 19.06B |